BackIntelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Total Liabilities

Latest total liabilities for IQMDU: $12M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$11.64M
44.61% YoYΔ $-9.37M vs prior year quarter

Peer trimmed avg / median

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Total Liabilities History

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) vs. peers: Total Liabilities Comparison

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) FAQ

The latest total liabilities for IQMDU is $12M as of December 2022. That compares with $21M in the prior-year period — down 44.6% year over year. Investors often review this figure alongside Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IQMDU's total liabilities moved from $21M to $12M — a 44.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s operating scale or balance-sheet position.

A total liabilities figure of $12M for IQMDU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IQMDU's total liabilities ($12M), review year-over-year change from $21M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.